Ajax Therapeutics News and Activities

Ajax Therapeutics is owned by Ajax Health.

Acquisition, funding and merger involving Ajax Health.

• Eli Lilly has announced the acquisition of Ajax Therapeutics  (posted on April 28 2026).

View the org chart displaying its 11 main executives

Most searched biographies at Ajax Therapeutics

• Martin Vogelbaum, Chief Executive Officer
• Ross Levine, Director
• Ming Cheah, Director

Popular executive movements at Ajax Therapeutics

• Scott Platshon, Director, has left the company  (posted on April 12 2026).

Create your alert
to follow the executive moves at Ajax Therapeutics.

Ajax Health has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Ajax Therapeutics

Social media about Ajax Therapeutics

• Ajax Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ajax Therapeutics on LinkedIn, X (Twitter) & YouTube